<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">SARS or MERS inactivated by physical (ultraviolet or radiation) or chemical (methanol, 
 <italic>Î²</italic>-propiolactone and formalin) methods has been shown to cause high levels of neutralizing antibodies and protective immunity in several animal models including mice, rabbit and ferret
 <xref rid="bib47" ref-type="bibr">47</xref>, 
 <xref rid="bib48" ref-type="bibr">48</xref>, 
 <xref rid="bib49" ref-type="bibr">49</xref>. However, eosinophil infiltration in the lungs of animals vaccinated with inactivated SARS-CoV vaccine or MERS-CoV vaccine has raised concerns about the safety and ultimate protective efficacy of inactivated vaccine
 <xref rid="bib50" ref-type="bibr">
  <sup>50</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib51" ref-type="bibr">
  <sup>51</sup>
 </xref>. In addition, a double-inactivated SARS-CoV (doubly inactivated by formalin and UV irradiation) vaccine provides poor protection against lethal disease in aged-animal models following heterologous challenge
 <xref rid="bib52" ref-type="bibr">
  <sup>52</sup>
 </xref>. This result may be attributed to respiratory dendritic cells (rDCs) migration to draining lymph nodes (DLNs) progressively decreases as mice age, decreases in virus-specific CD8
 <sup>+</sup> T cell responses in lungs and more severe disease in older mice infected with SARS-CoV
 <xref rid="bib53" ref-type="bibr">
  <sup>53</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib54" ref-type="bibr">
  <sup>54</sup>
 </xref>. Based on the above results, candidate vaccines against emerging coronaviruses should emphasize the efficacy in older animal with virus infection.
</p>
